Proleukin Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Description

Proleukin is the brand name for aldesleukin, a recombinant form of interleukin-2 (IL-2), a naturally occurring protein in the body. As a biologic therapy, Proleukin is primarily used in oncology and immunotherapy. It works by stimulating the growth and activity of specific white blood cells (lymphocytes), boosting the immune system's ability to identify and target cancer cells.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main formulations of proleukin include injection, powder, and others. Proleukin injection is a liquid form of aldesleukin, a recombinant interleukin-2, used for immune system modulation. It is indicated for various clinical conditions, including metastatic renal cell carcinoma (RCC), non-small cell lung cancer (NSCLC), and other therapeutic areas in oncology, immunology, and beyond. Proleukin is distributed through both online and offline channels and is used in hospitals and pharmacies for both adult and pediatric patients.

The proleukin market research report is one of a series of new reports from The Business Research Company that provides proleukin market statistics, including proleukin industry global market size, regional shares, competitors with a proleukin market share, detailed proleukin market segments, market trends and opportunities, and any further data you may need to thrive in the proleukin industry. This proleukin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The proleukin market size is expected to see strong growth in the next few years. It will grow to $1,581.3 million in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to rising demand for effective treatments in advanced cancer stages, growing demand for advanced treatments for rare cancers, growing clinical evidence supporting proleukin's efficacy, increasing support from healthcare organizations for immuno-oncology treatments, increasing number of cancer patients. Major trends in the forecast period include advancements in biologic therapies, development of combination therapies using proleukin, technological advancements, strategic collaborations and partnerships, advancements in cancer vaccine development.

The growing cancer disease is expected to drive the growth of the proleukin market going forward. Cancer is a group of diseases marked by the uncontrolled growth and spread of abnormal cells, which can invade surrounding tissues and metastasize to other body parts. The increasing prevalence of cancer is driven by an aging population, improved detection methods, lifestyle changes, environmental exposures, and better survival rates. Proleukin, a high-dose interleukin-2 therapy, stimulates the immune system to target and destroy cancer cells, offering potential treatment for advanced cancers such as metastatic melanoma and renal cell carcinoma. For instance, in February 2024, the World Health Organization reported an estimated 20 million new cancer cases in 2022, with projections indicating over 35 million new cases by 2050. Therefore, the growing cancer disease is driving the growth of the Proleukin market.

The increasing research and development activities are expected to drive the growth of the proleukin market going forward. Research and development (R&D) involves scientific efforts to create innovative products, improve existing ones, and develop new solutions. R&D activities are rising due to the demand for technological advancements and the need to address emerging global challenges. Increased R&D in the pharmaceutical industry contributes to enhancing Proleukin's efficacy, exploring new cancer indications, improving delivery methods, and reducing side effects, which expands its clinical use. For example, in July 2024, the Department of Health and Social Care reported that the UK spent $11.3 billion on pharmaceutical R&D in 2022. Therefore, the increasing research and development activities are driving the growth of the Proleukin market.

In May 2023, Iovance Biotherapeutics, a US-based biotechnology company focused on T-cell-based cancer immunotherapies, acquired Proleukin (aldesleukin) from Clinigen Limited for an undisclosed amount. This acquisition allows Iovance to enhance its T-cell-based cancer immunotherapy platform by integrating Proleukin, a key immunotherapy agent. By incorporating Proleukin into its tumor-infiltrating lymphocyte (TIL) therapies, Iovance aims to improve the effectiveness of these therapies and further advance its pipeline of innovative cancer treatments. This acquisition strengthens Iovance's position in the competitive oncology market. Clinigen Group, a UK-based company, was the previous provider of Proleukin (aldesleukin).

Key player operating in the proleukin market is Novartis Pharmaceuticals Corporation

North America was the largest region in the proleukin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in proleukin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the proleukin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The proleukin market consists of sales of cancer vaccines, biosimilars, immune checkpoint inhibitors and adjuvants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Proleukin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on proleukin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for proleukin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The proleukin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Injection; Powder; Other Types
2) By Therapeutic Area: Oncology; Immunology; Other Therapeutic Areas
3) By Clinical Indication: Metastatic Renal Cell Carcinoma (RCC); Non-Small Cell Lung Cancer (NSCLC); Other Indications
4) By Application: Hospital; Pharmacy
5) By End-User: Adults; Pediatrics
Companies Mentioned: Novartis Pharmaceuticals Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33109

1. Executive Summary

2. Proleukin Market Characteristics

3. Proleukin Market Biologic Drug Characteristics

3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy

4. Proleukin Market Trends And Strategies

5. Proleukin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Proleukin Growth Analysis And Strategic Analysis Framework

6.1. Global Proleukin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Proleukin Market Growth Rate Analysis
6.4. Global Proleukin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Proleukin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Proleukin Total Addressable Market (TAM)

7. Global Proleukin Market Pricing Analysis & Forecasts

8. Proleukin Market Segmentation

8.1. Global Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injection
Powder
Other Types
8.2. Global Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Immunology
Other Therapeutic Areas
8.3. Global Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metastatic Renal Cell Carcinoma (RCC)
Non-Small Cell Lung Cancer (NSCLC)
Other Indications
8.4. Global Proleukin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Pharmacy
8.5. Global Proleukin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adults
Pediatrics

9. Global Proleukin Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications

10. Proleukin Market Regional And Country Analysis

10.1. Global Proleukin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Proleukin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Proleukin Market

11.1. Asia-Pacific Proleukin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Proleukin Market

12.1. China Proleukin Market Overview
12.2. China Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Proleukin Market

13.1. India Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Proleukin Market

14.1. Japan Proleukin Market Overview
14.2. Japan Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Proleukin Market

15.1. Australia Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Proleukin Market

16.1. South Korea Proleukin Market Overview
16.2. South Korea Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Proleukin Market

17.1. Western Europe Proleukin Market Overview
17.2. Western Europe Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Proleukin Market

18.1. UK Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Proleukin Market

19.1. Germany Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Proleukin Market

20.1. France Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Proleukin Market

21.1. Eastern Europe Proleukin Market Overview
21.2. Eastern Europe Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Proleukin Market

22.1. North America Proleukin Market Overview
22.2. North America Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Proleukin Market

23.1. USA Proleukin Market Overview
23.2. USA Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Proleukin Market

24.1. Canada Proleukin Market Overview
24.2. Canada Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Proleukin Market

25.1. South America Proleukin Market Overview
25.2. South America Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Proleukin Market

26.1. Middle East Proleukin Market Overview
26.2. Middle East Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Proleukin Market

27.1. Africa Proleukin Market Overview
27.2. Africa Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Proleukin Market Competitive Landscape And Company Profiles

28.1. Proleukin Market Competitive Landscape
28.2. Proleukin Market Company Profiles
- 28.2.1. Novartis Pharmaceuticals Corporation Overview, Products and Services, Strategy and Financial Analysis

29. Global Proleukin Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Proleukin Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Proleukin Market

32. Recent Developments In The Proleukin Market

33. Proleukin Market High Potential Countries, Segments and Strategies

33.1 Proleukin Market In 2029 - Countries Offering Most New Opportunities
33.2 Proleukin Market In 2029 - Segments Offering Most New Opportunities
33.3 Proleukin Market In 2029 - Growth Strategies
- 33.3.1 Market Trend Based Strategies
- 33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. The Business Research Company
34.6. Copyright And Disclaimer